Vertex Pharmaceuticals Competitors and Similar CompaniesClear all
Vertex Pharmaceuticals's competitors and similar companies include ReCode Therapeutics, Arcturus Therapeutics, 4D Molecular Therapeutics, Spirovant Sciences and Yumanity Therapeutics.
 Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  Arcturus Therapeutics Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company. |  4D Molecular Therapeutics 4D Molecular Therapeutics is a company focused on creation of gene therapy products to cure genetic diseases. |  Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. |  Yumanity Therapeutics Yumanity Therapeutics (formerly known as Proteostasis Therapeutics) is a biopharmaceutical company developing therapeutics to treat diseases caused by an imbalance in the proteostasis network. | |
Founding Date | Founding Date 1989 | Founding Date 2015 | Founding Date 2013 | Founding Date 2013 | Founding Date 2016 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | ||||||
Locations | Locations Menlo Park, US HQ Dallas, US | Locations San Diego, US HQ | Locations Emeryville, US HQ | Locations Philadelphia, US HQ | Locations Boston, US HQ | |
Employees | Employees 5,40013% increase | Employees 1272% decrease | Employees 170 | Employees 14013% increase | Employees 323% decrease | Employees 4434% decrease |
Valuation ($) | Valuation ($) 123.5 b | Valuation ($) N/A | Valuation ($) 538.4 m | Valuation ($) 817 m | Valuation ($) N/A | Valuation ($) 15.7 m |
Financial | ||||||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $166.8m (FY, 2023) | Revenue (est.) $20.7m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $5.4m (FY, 2023) |
Net income | Net income $3.6b (FY, 2023) | Net income N/A | Net income ($29.7m) (FY, 2023) | Net income ($100.8m) (FY, 2023) | Net income N/A | Net income ($14.1m) (FY, 2023) |
Funding | ||||||
Total funding raised | Total funding raised $ 2.4m | Total funding raised $ 82m | Total funding raised N/A | Total funding raised $ 100m | Total funding raised N/A | Total funding raised $ 82m |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
127↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View companyArcturus Therapeutics
HQ
San Diego, US
Employees
170
Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company.
View company4D Molecular Therapeutics
HQ
Emeryville, US
Employees
140↑ 13% increase
4D Molecular Therapeutics is a company focused on creation of gene therapy products to cure genetic diseases.
View companySpirovant Sciences
HQ
Philadelphia, US
Employees
32↓ 3% decrease
Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
View company